Self-carried nanodrug (SCND-SIS3): A targeted therapy for lung cancer with superior biocompatibility and immune boosting effects.
Biomaterials
; 288: 121730, 2022 09.
Article
in En
| MEDLINE
| ID: mdl-35995622
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma
/
Nanoparticles
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
Biomaterials
Year:
2022
Document type:
Article
Country of publication:
Netherlands